Research

Research

Evaluating Progress in Health Care


PMC studies how personalized medicine is reshaping the health care landscape with attention to the emergence of new tests and treatments as well as the policies and practices that influence whether personalized health care strategies are utilized in clinical settings.


2022




Personalized Medicine at FDA:
The Scope & Significance of
Progress in 2021






"Comparison of FDA Table of
Pharmacogenetic Associations
and Clinical Pharmacogenetics
Implementation Consortium
Guidelines," American Journal
of Health-System Pharmacy



2021




Personalized Medicine at FDA:
The Scope & Significance of
Progress in 2020



2020




Personalized Medicine at FDA:
The Scope & Significance of
Progress in 2019






Understanding Genomic Testing Utilization and Coverage in the US




The Personalized Medicine Report: Opportunity, Challenges, and the Future (Sixth Edition)


2019




Personalized Medicine at FDA:
A Progress & Outlook Report






The Evolution of Biomarker Use in Clinical Trials for Cancer Treatments: Key Findings and Implications

2018




Personalized Medicine at FDA: 2017 Progress Report


2017




Personalized Medicine at FDA:
2016 Progress Report






The Personalized Medicine Report: Opportunity, Challenges, and the Future (Fifth Edition)

2015




Biopharmaceutical Companies’ Personalized Medicine Research Yields Innovative Treatments for Patients


Research Lead


Daryl Pritchard, Ph.D., Senior Vice President, Science Policy


Research Assistant


Lindsay Stephens, Program Manager & Secretary to the Board